Hb Bart's levels in cord blood and α-thalassemia mutations in Cyprus

被引:31
作者
Kyriacou, K
Kyrri, A
Kalogirou, E
Vasiliades, P
Angastiniotis, M
Ioannou, PA
Kleanthous, M
机构
[1] Cyprus Inst Neurol & Genet, Thalassaemia Lab, CY-1683 Nicosia, Cyprus
[2] Archbishop Makarios III Hosp, Cyprus Thalassaemia Ctr, CY-1474 Nicosia, Cyprus
关键词
D O I
10.3109/03630260008997525
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of this study was to examine the frequency of alpha-thalassemia in the population of Cyprus using cord blood samples. The levels of Hb Bart's were compared with the hematological indices and the results correlated with the presence of alpha-thalassemia mutations. The protocols for the polymerase chain reaction detection of the six most common alpha-globin mutations encountered in Cyprus were optimized, and the frequency of each mutation was determined through the screening of 495 random cord blood samples. The total allele frequency for the mutations examined was 10.6%, of which 1% is due to the triplication of the alpha-globin genes. The -alpha(3.7 kb) deletion accounts for 72.8% of all detectable mutations, while the - -1MED-I and -(alpha)-20.5 kb mutations account for 7.8%. The level of Hb Bart's and the MCV and MCH values incord blood samples were found to correlate closely with the severity of alpha-thalassemia, although the -alpha(3.7 kb) deletion and perhaps other mild alpha-thalassemia mutations may not give detectable Hb Bart's levels. A reasonably accurate estimate of the alpha-thalassemia carrier frequency may be obtained from cord blood studies if Bb Bart's estimates are combined with hematological indices. When molecular methods are added, these give the best way to use cord bloods to survey populations for alpha-thalassemia.
引用
收藏
页码:171 / 180
页数:10
相关论文
共 37 条
[1]  
ALPERIN JB, 1977, AM J CLIN PATHOL, V67, P219
[2]  
ANGASTINIOTIS MA, 1981, LANCET, V1, P369
[3]   THALASSEMIA IN CYPRUS [J].
ASHIOTIS, T ;
ZACHARIADIS, Z ;
SOFRONIADOU, K ;
LOUKOPOULOS, D ;
STAMATOYANNOPOULOS, G .
BMJ-BRITISH MEDICAL JOURNAL, 1973, 2 (5857) :38-42
[4]   ALPHA-THALASSEMIA IN THE POPULATION OF CYPRUS [J].
BAYSAL, E ;
KLEANTHOUS, M ;
BOZKURT, G ;
KYRRI, A ;
KALOGIROU, E ;
ANGASTINIOTIS, M ;
IOANNOU, P ;
HUISMAN, THJ .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (03) :496-499
[5]   DETECTION OF COMMON DELETIONAL ALPHA-THALASSEMIA-2 DETERMINANTS BY PCR [J].
BAYSAL, E ;
HUISMAN, THJ .
AMERICAN JOURNAL OF HEMATOLOGY, 1994, 46 (03) :208-213
[6]   A PCR-BASED STRATEGY TO DETECT THE COMMON SEVERE DETERMINANTS OF ALPHA-THALASSEMIA [J].
BOWDEN, DK ;
VICKERS, MA ;
HIGGS, DR .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 81 (01) :104-108
[7]  
BREUNING MH, 1987, HUM GENET, V76, P287
[8]   LOCALIZATION OF HUMAN ALPHA-GLOBIN TO 16P13.3-]PTER [J].
BUCKLE, VJ ;
HIGGS, DR ;
WILKIE, AOM ;
SUPER, M ;
WEATHERALL, DJ .
JOURNAL OF MEDICAL GENETICS, 1988, 25 (12) :847-849
[9]   CASE OF INTRAUTERINE DEATH DUE TO ALPHA-THALASSAEMIA [J].
DIAMOND, MP ;
COTGROVE, I ;
PARKER, A .
BRITISH MEDICAL JOURNAL, 1965, 2 (5456) :278-&
[10]   α-thalassemia in the United Arab Emirates [J].
El-Kalla, S ;
Baysal, E .
ACTA HAEMATOLOGICA, 1998, 100 (01) :49-53